Large-scale exploration and analysis of drug combinations

Bioinformatics

Volumn 31, Issue 12, 2015, Pages 2007-2016

  Li, Peng ^a   Huang, Chao ^a   Fu, Yingxue ^a   Wang, Jinan ^a   Wu, Ziyin ^a   Ru, Jinlong ^a   Zheng, Chunli ^a   Guo, Zihu ^a   Chen, Xuetong ^a   Zhou, Wei ^a   Zhang, Wenjuan ^a   Li, Yan ^b   Chen, Jianxin ^c   Lu, Aiping ^d   Wang, Yonghua ^a  

^a NORTHWEST A F UNIVERSITY   (China)

^b DALIAN UNIVERSITY OF TECHNOLOGY   (China)

^c BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^d HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG COMBINATION;

ADVERSE DRUG REACTION; ALGORITHM; BAYES THEOREM; BIOLOGY; DRUG COMBINATION; DRUG DATABASE; DRUG INTERACTION; DRUG POTENTIATION; HUMAN; PROBABILITY; PROCEDURES; THEORETICAL MODEL;

ALGORITHMS; BAYES THEOREM; COMPUTATIONAL BIOLOGY; DATABASES, PHARMACEUTICAL; DRUG COMBINATIONS; DRUG INTERACTIONS; DRUG SYNERGISM; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; MODELS, THEORETICAL; PROBABILITY;

EID: 84931043644     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btv080     Document Type: Article

References (57)

1. Al-Lazikani, B. et al. (2012) Combinatorial drug therapy for cancer in the postgenomic era. Nat. Biotechnol., 30, 679-692
2. Ashburner, M. et al. (2000) Gene Ontology: tool for the unification of biology. Nat. Genet., 25, 25-29
3. Bleakley, K. and Yamanishi, Y. (2009) Supervised prediction of drug-target interactions using bipartite local models. Bioinformatics, 25, 2397-2403
4. Boobis, A. et al. (2002) In silico prediction of ADME and pharmacokinetics: report of an expert meeting organised by COST B15. Eur. J. Pharm. Sci., 17, 183-193
5. Borisy, A.A. et al. (2003) Systematic discovery of multicomponent therapeutics. Proc. Natl Acad. Sci., 100, 7977-7982
6. Brouwers, L. et al. (2011) Network neighbors of drug targets contribute to drug side-effect similarity. PLoS One, 6, e22187
7. Chou, T.-C. (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol. Rev., 58, 621-681
8. Chou, T.-C. (2010) Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res., 70, 440-446
9. Cokol, M. et al. (2011) Systematic exploration of synergistic drug pairs. Mol. Syst. Biol., 7, 544
10. Dancey, J. and Sausville, E.A. (2003) Issues and progress with protein kinase inhibitors for cancer treatment. Nat. Rev. Drug Discov., 2, 296-313
11. Davis, J. and Goadrich, M. (2006) The relationship between Precision-Recall and ROC curves. In: Proceedings of the 23rd international conference on Machine learning. ACM, pp. 233-240
12. Eichler, H.G. et al. (2008) Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma. Nat. Rev. Drug Discov., 7, 818-826
13. Fitzgerald, J.B. et al. (2006) Systems biology and combination therapy in the quest for clinical efficacy. Nat. Chem. Biol., 2, 458-466
14. Garrison, L.P., Jr. et al. (2007) Assessing a structured, quantitative health outcomes approach to drug risk-benefit analysis. Health Aff. (Millwood). 26, 684-695
15. Gottlieb, A. et al. (2012) INDI: a computational framework for inferring drug interactions and their associated recommendations. Mol. Syst. Biol., 8, 592
16. Huang, J. et al. (2013) Systematic prediction of pharmacodynamic drug-drug interactions through protein-protein-interaction network. PLoS Comp. Biol., 9, e1002998
17. Jain, E. et al. (2009) Infrastructure for the life sciences: design and implementation of the UniProt website. BMC Bioinformatics, 10, 136
18. Jansen, R. et al. (2003) A Bayesian networks approach for predicting protein-protein interactions from genomic data. Science, 302, 449-453
19. Jia, J. et al. (2009) Mechanisms of drug combinations: interaction and network perspectives. Nat. Rev. Drug Discov., 8, 111-128
20. Jonker, D.M. et al. (2005) Towards a mechanism-based analysis of pharmacodynamic drug-drug interactions in vivo. Pharmacol. Ther., 106, 1-18
21. Knox, C. et al. (2011) DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res., 39, D1035-D1041
22. Konc, J. and Janežič, D. (2014). Binding site comparison for function prediction and pharmaceutical discovery. Curr. Opin. Struct. Biol., 25, 34-39
23. Kuhn, M. et al. (2010) A side effect resource to capture phenotypic effects of drugs. Mol. Syst. Biol., 6, 343
24. Lee, J.L. et al. (2008) A phase II study of docetaxel as salvage chemotherapy in advanced gastric cancer after failure of fluoropyrimidine and platinum combination chemotherapy. Cancer Chemother. Pharmacol., 61, 631-637
25. Lehá r, J. et al. (2009) Synergistic drug combinations tend to improve therapeutically relevant selectivity. Nat. Biotechnol., 27, 659-666
26. Li, L. et al. (2007) Drug-drug interaction prediction: a Bayesian meta-Analysis approach. Stat. Med., 26, 3700-3721
27. Li, P. et al. (2014) Systems pharmacology strategies for drug discovery and combination with applications to cardiovascular diseases. J. Ethnopharmacol., 151, 93-107
28. Lin, D. (1998) An information-theoretic definition of similarity. ICML. Morgan Kaufman Publishers, San Francisco, pp. 296-304
29. Liu, Y. et al. (2010) DCDB: drug combination database. Bioinformatics, 26, 587-588
30. Manzi, S.F. and Shannon, M. (2005) Drug interactions-A review. Clin. Pediatric Emer. Med., 6, 93-102
31. Ovaska, K. et al. (2008) Fast Gene Ontology based clustering for microarray experiments. BioData Mining, 1, 11
32. Pauwels, Eet al. (2011) Predicting drug side-effect profiles: a chemical fragmentbased approach.BMC Bioinformatics, 12, 169
33. Pearson, W.R. (1998) Empirical statistical estimates for sequence similarity searches. J. Mol. Biol., 276, 71-84
34. Perlman, L. et al. (2011) Combining drug and gene similarity measures for drug-target elucidation. J. Comput. Biol., 18, 133-145
35. Ramaswamy, S. (2007) Rational design of cancer-drug combinations. N. Engl. J. Med., 357, 299-300
36. Resnik, P. (2011) Semantic similarity in a taxonomy: an information-based measure and its application to problems of ambiguity in natural language. arXiv preprint arXiv: 1105.5444
37. Roemer, T. and Boone, C. (2013) Systems-level antimicrobial drug and drug synergy discovery. Nat. Chem. Biol., 9, 222-231
38. RxList, R (2008) The Internet Drug Index, AldactoneVR , (spironolactone) Tablets, USP, 1-8
39. Salahuddin, A. et al. (2013) Combination therapy for hypertension 2013: an update. J. Am. Soc. Hypertension JASH, 7, 401-407
40. Shaheen, R.M. et al. (2001) Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms. Cancer Res., 61, 1464-1468
41. Sharan, R. et al. (2007) Network-based prediction of protein function. Mol. Syst. Biol., 3
42. Skrbo, A. et al. (2004) Classification of drugs using the ATC system (Anatomic, Therapeutic, Chemical Classification) and the latest changes]. Med. Arh., 58, 138
43. Smith, T.F. et al. (1985) The statistical distribution of nucleic acid similarities. Nucleic Acids Res., 13, 645-656
44. Spader, T.B. et al. (2013) Synergysm of voriconazole or itraconazole with other antifungal agents against species of Fusarium. Rev. Iberoam Micol., 30, 200-204
45. Steinbeck, C. et al. (2006) Recent developments of the chemistry development kit (CDK)-An open-source java library for chemo-And bioinformatics. Curr. Pharm. Des., 12, 2111-2120
46. Sun, X. et al. (2013) High-throughput methods for combinatorial drug discovery. Sci. Transl. Med., 5, 205rv201-205rv201
47. Tan, X. et al. (2012) Systematic identification of synergistic drug pairs targeting HIV. Nat. Biotechnol., 30, 1125-1130
48. Tang, J. et al. (2013) Target inhibition networks: predicting selective combinations of druggable targets to block cancer survival pathways. PLoS Comp. Biol., 9, e1003226
49. Wang, X. et al. (2012) A systems biology approach to uncovering pharmacological synergy in herbal medicines with applications to cardiovascular disease. Evid. Based Complement Alternat. Med., 2012, 519031
50. Wang, Y.C. et al. (2013) Network predicting drug's anatomical therapeutic chemical code. Bioinformatics, 29, 1317-1324
51. Winter, G.E. et al. (2012) Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML. Nat. Chem. Biol., 8, 905-912
52. Yao, Y. et al. (2013) Deciphering the combination principles of Traditional Chinese Medicine from a systems pharmacology perspective based on Mahuang Decoction. J. Ethnopharmacol., 150, 619-638
53. Zhang, L. et al. (2009) Predicting drug-drug interactions: an FDA perspective. AAPS J., 11, 300-306
54. Zhao, S. et al. (2013) Systems pharmacology of adverse event mitigation by drug combinations. Sci. Transl. Med., 5, 206ra140
55. Zhao, X.-M. et al. (2011) Prediction of drug combinations by integrating molecular and pharmacological data. PLoS Comp. Biol., 7, e1002323
56. Zhu, F. et al. (2010) Update of TTD: therapeutic target database. Nucleic Acids Res., 38, D787-D791
57. Zimmermann, G.R. et al. (2007) Multi-target therapeutics: when the whole is greater than the sum of the parts. Drug Discov. Today, 12, 34-42